(Global Executive Moves is a news service brought to you by Kingsley Gate Partners. This should not to be construed as placements made by KGP.)
Private Equity Industry Banner
Mouse Scroll Icon
November 2022

Areteia Therapeutics Appoints Christopher Courts as Chief Financial Officer

Areteia Therapeutics announced the appointment of Christopher Courts, CPA as Chief Financial Officer. Christopher is a seasoned industry executive with over 20 years of experience in public and private life science companies. 

Areteia Therapeutics is a biotechnology company committed to putting asthma patients in better control of their disease.